Showing results (491-500 of 778) with videos related to
Sort By:
Pageof 78
Stem Cell Research|June 15, 2016
Generation of functional podocytes from human induced pluripotent stem cellsOsele Ciampi, Roberto Iacone, Lorena Longaretti, et al.Clinical Journal of the American Society of Nephrology : CJASN|November 22, 2022
Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without DiabetesPriya Vart, Muthiah Vaduganathan, Niels Jongs, et al.Acta Diabetologica|October 14, 2021
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trialFabiola Carrara, Piero Ruggenenti, Annalisa Perna, et al.Nephron|November 5, 2023
Functional Magnetic Resonance Imaging to Monitor Disease Progression: A Prospective Study in Patients with Primary Membranoproliferative GlomerulonephritisGiulia Villa, Erica Daina, Paolo Brambilla, et al.Kidney International|August 8, 2002
Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1Carla Zoja, Stefania Angioletti, Roberta Donadelli, et al.JCI Insight|March 13, 2020
C3a receptor blockade protects podocytes from injury in diabetic nephropathyMarina Morigi, Luca Perico, Daniela Corna, et al.JCI Insight|September 20, 2019
Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytesValentina Benedetti, Angelo Michele Lavecchia, Monica Locatelli, et al.Journal of the American Society of Nephrology : JASN|June 7, 2014
A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulationElisabetta Valoti, Marta Alberti, Agustin Tortajada, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trialAneliya Parvanova, Irene M van der Meer, Ilian Iliev, et al.Journal of the American Society of Nephrology : JASN|December 8, 2004
Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial resultsGiuseppe Remuzzi, Piero Ruggenenti, Annalisa Perna, et al.Pageof 78